Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
103
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Bicara Therapeutics Inc. market cap is $637.32M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bicara Therapeutics Inc. 52 week high is $30.99 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bicara Therapeutics Inc. 52 week low is $7.87 as of November 18, 2026.
Bicara Therapeutics Inc. stock price today is $9.37.
Bicara Therapeutics Inc. stock price yesterday was $9.60.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Bicara Therapeutics Inc.'s P/E ratio is -2.77.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Bicara Therapeutics Inc. P/B ratio is 1.5559.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Bicara Therapeutics Inc. 50-day moving average is $16.29.